Financhill
Sell
45

RTX Quote, Financials, Valuation and Earnings

Last price:
$116.49
Seasonality move :
6.25%
Day range:
$114.60 - $116.78
52-week range:
$82.04 - $128.70
Dividend yield:
2.13%
P/E ratio:
33.28x
P/S ratio:
1.98x
P/B ratio:
2.54x
Volume:
11M
Avg. volume:
4.7M
1-year change:
42.68%
Market cap:
$155B
Revenue:
$68.9B
EPS (TTM):
$3.50
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $45.3B $56.6B $64.4B $67.1B $68.9B
Revenue Growth (YoY) 30.69% 24.78% 13.79% 4.17% 2.75%
 
Cost of Revenues $34.6B $48.1B $51.9B $53.4B $56.8B
Gross Profit $10.8B $8.5B $12.5B $13.7B $12.1B
Gross Profit Margin 23.71% 15.08% 19.4% 20.38% 17.54%
 
R&D Expenses $2.5B $2.6B $2.7B $2.7B $2.8B
Selling, General & Admin $3.7B $5.5B $5B $5.6B $5.8B
Other Inc / (Exp) $829M -$2.3B $1.3B $1.8B $1.8B
Operating Expenses $5.8B $7.2B $7.4B $8.2B $8.5B
Operating Income $4.9B $1.3B $5.1B $5.5B $3.6B
 
Net Interest Expenses $1.6B $1.4B $1.3B $1.2B $1.6B
EBT. Incl. Unusual Items $4.2B -$2.4B $5.1B $6.1B $3.8B
Earnings of Discontinued Ops. $2.2B -$367M -$33M -$19M --
Income Tax Expense $421M $575M $964M $790M $456M
Net Income to Company $3.7B -$2.9B $4.1B $5.3B $3.4B
 
Minority Interest in Earnings -$411M -$224M -$248M -$111M -$185M
Net Income to Common Excl Extra Items $5.5B -$3.5B $3.9B $5.2B $3.2B
 
Basic EPS (Cont. Ops) $6.48 -$2.59 $2.57 $3.52 $2.24
Diluted EPS (Cont. Ops) $6.41 -$2.59 $2.56 $3.50 $2.23
Weighted Average Basic Share $854.8M $1.4B $1.5B $1.5B $1.4B
Weighted Average Diluted Share $863.9M $1.4B $1.5B $1.5B $1.4B
 
EBITDA $8.6B $3.2B $11B $11.5B $9.7B
EBIT $5.9B -$945M $6.4B $7.4B $5.5B
 
Revenue (Reported) $45.3B $56.6B $64.4B $67.1B $68.9B
Operating Income (Reported) $4.9B $1.3B $5.1B $5.5B $3.6B
Operating Income (Adjusted) $5.9B -$945M $6.4B $7.4B $5.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $14.7B $16.2B $17B $13.5B $20.1B
Revenue Growth (YoY) 29.67% 9.94% 4.55% -20.57% 49.21%
 
Cost of Revenues $13B $13.1B $13.5B $12.8B $16.1B
Gross Profit $1.7B $3.1B $3.5B $714M $4B
Gross Profit Margin 11.82% 19.27% 20.57% 5.3% 20.08%
 
R&D Expenses $642M $676M $662M $712M $751M
Selling, General & Admin $1.4B $1.2B $1.4B $1.4B $1.4B
Other Inc / (Exp) $253M $460M $473M $446M $381M
Operating Expenses $1.3B $1.8B $2B $2.1B $2B
Operating Income $434M $1.3B $1.5B -$1.4B $2B
 
Net Interest Expenses $350M $327M $316M $372M $503M
EBT. Incl. Unusual Items $337M $1.5B $1.7B -$1.3B $1.9B
Earnings of Discontinued Ops. $113M -$7M -- -- --
Income Tax Expense $152M $3M $282M -$389M $371M
Net Income to Company $185M $1.5B $1.4B -$933M $1.5B
 
Minority Interest in Earnings -$34M -$73M -$8M -$51M -$63M
Net Income to Common Excl Extra Items $264M $1.4B $1.4B -$984M $1.5B
 
Basic EPS (Cont. Ops) $0.17 $0.93 $0.94 -$0.68 $1.10
Diluted EPS (Cont. Ops) $0.17 $0.93 $0.94 -$0.68 $1.09
Weighted Average Basic Share $1.5B $1.5B $1.5B $1.4B $1.3B
Weighted Average Diluted Share $1.5B $1.5B $1.5B $1.4B $1.3B
 
EBITDA $1.9B $3B $3.1B $143M $3.5B
EBIT $693M $1.8B $2B -$931M $2.5B
 
Revenue (Reported) $14.7B $16.2B $17B $13.5B $20.1B
Operating Income (Reported) $434M $1.3B $1.5B -$1.4B $2B
Operating Income (Adjusted) $693M $1.8B $2B -$931M $2.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $51.9B $63.8B $66B $67.1B $79B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $42.9B $52.5B $52.5B $55.4B $63.9B
Gross Profit $9B $11.2B $13.5B $11.6B $15.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $2.5B $2.6B $2.8B $2.8B $2.9B
Selling, General & Admin $5.2B $5.2B $5.5B $4.9B $4.9B
Other Inc / (Exp) -$2.4B $1.8B $1.3B $947M $834M
Operating Expenses $6.8B $7.5B $8.1B $7.5B $8.2B
Operating Income $2.1B $3.7B $5.4B $4.2B $7B
 
Net Interest Expenses $1.4B $1.3B $1.2B $1.4B $1.9B
EBT. Incl. Unusual Items -$1.7B $4.1B $5.5B $3.7B $5.9B
Earnings of Discontinued Ops. $320M -$45M -$18M -- --
Income Tax Expense $709M $512M $832M $366M $994M
Net Income to Company -$2.4B $3.6B $4.6B $3.4B $4.9B
 
Minority Interest in Earnings -$419M -$231M -$151M -$184M -$208M
Net Income to Common Excl Extra Items -$2.5B $3.3B $4.5B $3.2B $4.7B
 
Basic EPS (Cont. Ops) -$1.15 $2.21 $3.01 $2.18 $3.52
Diluted EPS (Cont. Ops) -$1.16 $2.20 $3.00 $2.15 $3.50
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $3.5B $10B $11B $9.4B $12.2B
EBIT -$226M $5.5B $6.8B $5.2B $7.9B
 
Revenue (Reported) $51.9B $63.8B $66B $67.1B $79B
Operating Income (Reported) $2.1B $3.7B $5.4B $4.2B $7B
Operating Income (Adjusted) -$226M $5.5B $6.8B $5.2B $7.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $40.2B $47.3B $49B $49B $59.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $33.8B $38.3B $38.9B $40.9B $47.9B
Gross Profit $6.4B $9.1B $10.1B $8.1B $11.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.9B $1.9B $2B $2B $2.1B
Selling, General & Admin $4.2B $3.8B $4.2B $3.5B $3.5B
Other Inc / (Exp) -$2.5B $1.5B $1.4B $482M $379M
Operating Expenses $5.2B $5.5B $6.2B $5.4B $6B
Operating Income $1.2B $3.5B $3.9B $2.7B $5.2B
 
Net Interest Expenses $1B $984M $914M $1.1B $1.4B
EBT. Incl. Unusual Items -$2.4B $4.1B $4.4B $2.1B $4.2B
Earnings of Discontinued Ops. -$356M -$34M -$19M -- --
Income Tax Expense $753M $690M $558M $194M $732M
Net Income to Company -$3.1B $3.4B $3.9B $1.9B $3.5B
 
Minority Interest in Earnings -$155M -$162M -$65M -$138M -$161M
Net Income to Common Excl Extra Items -$3.7B $3.2B $3.8B $1.8B $3.3B
 
Basic EPS (Cont. Ops) -$2.48 $2.12 $2.55 $1.21 $2.47
Diluted EPS (Cont. Ops) -$2.48 $2.11 $2.54 $1.19 $2.45
Weighted Average Basic Share $3.9B $4.5B $4.4B $4.4B $4B
Weighted Average Diluted Share $3.9B $4.5B $4.5B $4.4B $4B
 
EBITDA $1.7B $8.5B $8.4B $6.4B $8.9B
EBIT -$1.3B $5.1B $5.4B $3.2B $5.6B
 
Revenue (Reported) $40.2B $47.3B $49B $49B $59.1B
Operating Income (Reported) $1.2B $3.5B $3.9B $2.7B $5.2B
Operating Income (Adjusted) -$1.3B $5.1B $5.4B $3.2B $5.6B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $4.9B $8.8B $7.8B $6.2B $6.6B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $8.7B $9.3B $9.7B $9.1B $10.8B
Inventory $9B $9.4B $9.2B $10.6B $11.8B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.6B $6B $4B $5B $7.1B
Total Current Assets $61.6B $43.4B $42.1B $42.4B $48.4B
 
Property Plant And Equipment $11.6B $16.8B $16.9B $17B $17.4B
Long-Term Investments $3.5B $3.1B $2.8B $2.6B $2.4B
Goodwill $36.6B $54.3B $54.4B $53.8B $53.7B
Other Intangibles $24.5B $40.5B $38.5B $36.8B $35.4B
Other Long-Term Assets $1.9B $4B $6.6B $6.2B $4.6B
Total Assets $139.6B $162.2B $161.4B $158.9B $161.9B
 
Accounts Payable $7.8B $8.6B $8.8B $9.9B $10.7B
Accrued Expenses $8.4B $10.5B $10.2B $11B $14.9B
Current Portion Of Long-Term Debt $5.6B $637M $158M -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $14.4B -- -- -- --
Total Current Liabilities $46.6B $35.8B $35.4B $39.1B $46.8B
 
Long-Term Debt $37.7B $31B $31.3B $30.7B $42.4B
Capital Leases -- -- -- -- --
Total Liabilities $95.3B $88.3B $86.7B $84.7B $100.4B
 
Common Stock $23B $36.9B $37.5B $37.9B $37.1B
Other Common Equity Adj -$10.1B -$3.7B -$1.9B -$2B -$2.4B
Common Equity $41.8B $72.2B $73.1B $72.6B $59.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $2.6B $1.7B $1.6B $1.6B $1.6B
Total Equity $44.3B $73.9B $74.7B $74.2B $61.4B
 
Total Liabilities and Equity $139.6B $162.2B $161.4B $158.9B $161.9B
Cash and Short Terms $4.9B $8.8B $7.8B $6.2B $6.6B
Total Debt $43.3B $31.8B $31.5B $31.9B $43.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $10B $7.5B $5.4B $5.5B $6.7B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $10.1B $9.5B $9.2B $10.1B $10.1B
Inventory $9.8B $9.4B $10.4B $12.1B $13.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $3.9B $4.7B $4.5B $6.3B $6.8B
Total Current Assets $43.5B $42B $41.8B $46.5B $51.8B
 
Property Plant And Equipment $16.8B $16.4B $16.5B $17.1B $17.7B
Long-Term Investments $3.3B $3B $2.6B $2.5B $2.3B
Goodwill $53.5B $53.8B $53.2B $53.9B $53.8B
Other Intangibles $41.6B $38.8B $37B $35.9B $34.2B
Other Long-Term Assets $3B $4.8B $7.1B $6.6B $5.1B
Total Assets $162.4B $158.8B $158.2B $162.4B $164.8B
 
Accounts Payable $8.1B $8.7B $9B $10.3B $11.8B
Accrued Expenses $13.6B $9.7B $11.2B $14.3B $16B
Current Portion Of Long-Term Debt $1.4B $320M -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $118M -- -- -- --
Total Current Liabilities $35.6B $34.1B $38.4B $45B $52.2B
 
Long-Term Debt $31.2B $30.8B $31.1B $32.7B $38.8B
Capital Leases -- -- -- -- --
Total Liabilities $92.3B $85.8B $86.5B $91.2B $102B
 
Common Stock $36.8B $37.3B $37.8B $38.4B $37.3B
Other Common Equity Adj -$8B -$3.9B -$4.1B -$2.1B -$2B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.7B $1.7B $1.6B $1.7B $1.7B
Total Equity $70.1B $73B $71.8B $71.2B $62.9B
 
Total Liabilities and Equity $162.4B $158.8B $158.2B $162.4B $164.8B
Cash and Short Terms $10B $7.5B $5.4B $5.5B $6.7B
Total Debt $32.8B $31.2B $33.4B $35.3B $42.2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $3.7B -$2.9B $4.1B $5.3B $3.4B
Depreciation & Amoritzation $2.7B $4.2B $4.6B $4.1B $4.2B
Stock-Based Compensation $268M $330M $442M $420M $425M
Change in Accounts Receivable -$591M $1.4B -$2.2B $203M -$2.6B
Change in Inventories -$1.3B $412M $163M -$1.6B -$1.1B
Cash From Operations $8.9B $3.6B $7.1B $7.2B $7.9B
 
Capital Expenditures $2.2B $2B $2.4B $2.8B $3.2B
Cash Acquisitions $125M $5.3B $791M $28M $6M
Cash From Investing -$3.1B $3.1B -$1.4B -$2.8B -$3B
 
Dividends Paid (Ex Special Dividend) -$2.4B -$2.7B -$3B -$3.1B -$3.2B
Special Dividend Paid
Long-Term Debt Issued -- $2B $4.1B $1M $22.9B
Long-Term Debt Repaid -$2.7B -$16.1B -$4.3B -$3M -$10.6B
Repurchase of Common Stock -$151M -$47M -$2.3B -$2.8B -$12.9B
Other Financing Activities $82M -$151M -$1.1B -$415M -$317M
Cash From Financing -$4.6B -$5.3B -$6.7B -$5.9B -$4.5B
 
Beginning Cash (CF) $6.2B $7.4B $8.8B $7.9B $6.3B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.2B $1.4B -$978M -$1.5B $317M
Ending Cash (CF) $4.9B $8.8B $7.8B $6.2B $6.6B
 
Levered Free Cash Flow $6.7B $1.6B $4.6B $4.4B $4.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $185M $1.5B $1.4B -$933M $1.5B
Depreciation & Amoritzation $1.2B $1.2B $1B $1.1B $1.1B
Stock-Based Compensation $118M $116M $106M $107M $105M
Change in Accounts Receivable -$273M -$1.3B $637M $53M -$647M
Change in Inventories $439M $76M -$401M -$108M -$344M
Cash From Operations $1.6B $1.9B $778M $3.3B $2.5B
 
Capital Expenditures $419M $511M $641M $786M $681M
Cash Acquisitions $2.3B -- -$60M $6M --
Cash From Investing $2.1B -$378M -$755M -$859M -$715M
 
Dividends Paid (Ex Special Dividend) -$688M -$751M -$794M -$838M -$823M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $15M $2B -- -- --
Long-Term Debt Repaid -$2.1B -$2.2B -- -$172M --
Repurchase of Common Stock -- -$993M -$616M -$1.4B -$294M
Other Financing Activities $14M -$67M -$43M -$33M -$29M
Cash From Financing -$692M -$2.1B $617M -$2.4B -$1.2B
 
Beginning Cash (CF) $7B $8.1B $4.8B $5.4B $6B
Foreign Exchange Rate Adjustment $21M -$69M -$37M -$15M $23M
Additions / Reductions $3B -$509M $640M $80M $650M
Ending Cash (CF) $10B $7.5B $5.4B $5.5B $6.7B
 
Levered Free Cash Flow $1.2B $1.4B $137M $2.5B $1.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$2.4B $3.6B $4.6B $3.4B $4.9B
Depreciation & Amoritzation $3.7B $4.6B $4.2B $4.2B $4.3B
Stock-Based Compensation $329M $420M $417M $421M $434M
Change in Accounts Receivable $1.4B -$1.4B -$1.3B -$1.2B -$2B
Change in Inventories -$122M $466M -$1.2B -$1.6B -$1.4B
Cash From Operations $5.1B $5.3B $5.7B $7.8B $10.3B
 
Capital Expenditures $2.1B $2B $2.9B $3.2B $3B
Cash Acquisitions $5.8B $630M -$249M $6M $1.3B
Cash From Investing $2.8B -$948M -$3.1B -$3B -$1.7B
 
Dividends Paid (Ex Special Dividend) -$2.6B -$2.9B -$3.1B -$3.3B -$3.2B
Special Dividend Paid
Long-Term Debt Issued -- -- $2.1B $3B $19.9B
Long-Term Debt Repaid -$19B -$1.5B -- -$176M -$12.1B
Repurchase of Common Stock -$87M -$2B -$2.7B -$3B -$10.7B
Other Financing Activities $35M -$402M -$1.1B -$276M -$398M
Cash From Financing -$5.2B -$6.9B -$4.5B -$4.8B -$7.4B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.7B -$2.6B -$2B $43M $1.2B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2.9B $3.3B $2.8B $4.6B $7.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$3.1B $3.4B $3.9B $1.9B $3.5B
Depreciation & Amoritzation $3B $3.4B $3.1B $3.2B $3.2B
Stock-Based Compensation $253M $343M $318M $319M $328M
Change in Accounts Receivable $1.3B -$1.5B -$678M -$2.1B -$1.5B
Change in Inventories -$111M -$57M -$1.4B -$1.4B -$1.7B
Cash From Operations $2.3B $4B $2.5B $3.2B $5.6B
 
Capital Expenditures $1.3B $1.3B $1.8B $2.1B $2B
Cash Acquisitions $5.8B $1.1B $28M $6M $1.3B
Cash From Investing $3.9B -$139M -$1.9B -$2.1B -$755M
 
Dividends Paid (Ex Special Dividend) -$2B -$2.2B -$2.3B -$2.5B -$2.4B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2B $2B -- $3B --
Long-Term Debt Repaid -$17.1B -$2.5B -$2M -$175M -$1.7B
Repurchase of Common Stock -$47M -$2B -$2.4B -$2.6B -$394M
Other Financing Activities -$85M -$336M -$329M -$190M -$271M
Cash From Financing -$3.5B -$5.2B -$3B -$1.9B -$4.7B
 
Beginning Cash (CF) $20.4B $25.5B $18.7B $17.6B $18.2B
Foreign Exchange Rate Adjustment -$65M $10M -$57M $4M $11M
Additions / Reductions $2.7B -$1.3B -$2.4B -$798M $94M
Ending Cash (CF) $23B $24.1B $16.2B $16.7B $18.3B
 
Levered Free Cash Flow $963M $2.6B $789M $1B $3.6B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock